Abbvie Inc
NYSE: ABBV
$211.77
+$0.22 (+0.1%)
Closing Price on March 14, 2025
ABBV Articles
Most Wall Street strategists agree that the way to play the fourth quarter and next year is with large cap stocks that pay and consistently increase their dividends.
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon Athletica, Nike and Rio Tinto.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated:
In a recent research note, the analysts at Jefferies made a big move by adding Ball Corp. to the firm's well-respected Franchise Picks list of stocks to buy.
Published:
Last Updated:
A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in the top position.
Published:
Last Updated:
AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.
Published:
Last Updated:
Despite the fact that energy has tumbled 20% from the highs posted in June, Jefferies remains bullish on the natural gas arena, and with good reason.
Published:
Last Updated:
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
Published:
Last Updated:
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
Published:
Last Updated:
SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new products, attractive dividends and solid performance as positives.
Published:
Last Updated:
In a study that ranks “perceived strength” of companies rather than their financial performance, Apple Inc. (NASDAQ: AAPL) took the top spot. Research firm Future Brand described it selection...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.